Zomedica stock rises ~15% on taking control of Truforma products via licensing deal

Jan. 18, 2023 6:29 AM ETZomedica Corp. (ZOM), ZOM:CABy: Ravikash, SA News Editor2 Comments

Two unrecognizable businesswomen shaking hands after a meeting


Zomedica (NYSE:ZOM) said it is restructuring its existing development and commercialization agreements with Qorvo Biotechnologies for the company's Truforma line of products.

Under the agreements, Zomedica will take control of aspects of the Truforma product line previously provided by Qorvo, including development of

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.